Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
CONCLUSION: These analyses demonstrated that quarterly or monthly treatment with fremanezumab significantly reduced headache severity and duration in patients with CM or EM, including in patients with documented inadequate response to two to four prior migraine preventive medication classes.PMID:34115380 | DOI:10.1111/head.14127
Source: Headache - Category: Neurology Authors: Messoud Ashina Joshua M Cohen Sanjay K Gandhi Evelyn Du Source Type: research